PE/Cyanine7 anti-mouse CD64 (FcI3RI) [X54-5/7.1] and 2 more items

BioLegend Inc. has been awarded contract A207_PO-0468627 by the University of Virginia, a state and local contracting organization in Virginia. The award was executed on August 13, 2026, with a cumulative contract value of $571. The specific products and services to be delivered, detailed period of performance, and place of performance information are not provided in the available contract documentation.

Without access to the full scope of work or technical specifications contained in the purchase order, the precise nature of deliverables under this contract cannot be definitively determined from the materials provided. However, given BioLegend Inc.'s industry specialization, the contract likely involves the provision of research reagents, antibodies, or related life sciences products for use by the University of Virginia. Additional contract documentation would be required to confirm the specific services, delivery locations, performance timeline, and detailed technical requirements associated with this award.